Careful consideration of patient selection criteria and possible side effects, such as gastrointestinal discomfort and hypoglycemia, will be important when using GLP-1RAs for the treatment of IIH
In REDEFINE 1, adults with obesity or overweight (without diabetes) treated with CagriSema had a mean body weight reduction of 20.4% at 68 weeks under the treatment-policy estimand, compared with 3.0% on placebo
"I have gained and lost 100lbs 3x so I never thought this moment could or would happen, but Im finally spring breakin wearin a BIKINI!!!!!!" Simpson captioned the selfie at the time
Braun TP, Orwoll B, Zhu X, Levasseur PR, Szumowski M, Nguyen ML, et al
Accessibility: Compounded formulations can sometimes bypass supply chain shortages, providing treatment to those unable to access brand-name options
Will you accept my insurance